Updates on management of nonvariceal upper gastrointestinal bleeding

Mohanad S. Awadalla, Michael Desimone, Wahid Wassef

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Purpose of reviewUpper gastrointestinal bleeding (UGIB) is a common and life-threatening condition in the United States and worldwide.Recent findingsThere have been several exciting recent advances in the endoscopic management of UGIB. One such advance is the recent approval of Hemospray by US Food and Drug Administration in May 2018. Another one is the emerging role of video capsule endoscopy as a triage and localization tool for UGIB patients. Finally, the development of new reversal agents for antithrombotic medications is an important advance in the management of life-threatening upper gastrointestinal bleed.SummaryIn this article, we will broadly review the management of nonvariceal UGIB, focusing primarily on the data addressing these new advances.

Original languageEnglish (US)
Pages (from-to)517-523
Number of pages7
JournalCurrent Opinion in Gastroenterology
Issue number6
StatePublished - Nov 1 2019
Externally publishedYes


  • andexanet alfa
  • Hemospray
  • idarucizumab
  • nonvariceal upper gastrointestinal bleeding
  • upper gastrointestinal bleeding
  • video capsule endoscopy

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Updates on management of nonvariceal upper gastrointestinal bleeding'. Together they form a unique fingerprint.

Cite this